In a recent interview with Stockhead, Sarah Hughan speaks with Dr. Camile Farah, CEO and Managing Director of Optiscan (ASX: OIL), to discuss the latest developments at the company.

Optiscan’s business development team has been actively working to penetrate a key segment of the U.S. market. The company’s non-invasive digital imaging technologies aim to bridge the gap between surgery and pathology.

Watch the interview to learn more about Optiscan’s innovative offerings, upcoming events in the U.S., and additional insights from Dr. Farah.

Watch the interview here.